RecruitingNot ApplicableNCT06627634

Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver

Gastric Cancer and Oligometastatic Liverinvolvement. Metastatectomy and Impact on Survival


Sponsor

Aarhus University Hospital

Enrollment

20 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Offering treatment with potential to cure for participants with no such offer in today's standard treatment options, by offering metastatectomia and standard treatment with intention to cure i.e., neoadjuvant chemotherapy and gastrectomy for participants with gastric- og gastroeusofageal junction cancer. Including 20 participants from all 4 centres in Denmark able to perform the surgical procedures in question. Endpoints: 2-year overall survival.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Age \> 18.
  • Presence of primary T1-T4N0-N3M1 adenocarcinoma of the stomach or GEJ and max. 30% liver involvement.
  • Primary tumour resectable, based on imaging workup.
  • Surgical operable patients with ASA-score36 ≤ III and WHO performance status37 0-1.
  • Patients eligible for treatment with systemic chemotherapy by FLOT regimen.
  • Informed consent is obtained.

Exclusion Criteria8

  • Patient with non-resectable cancer.
  • Direct growth involving adjacent organs, i.e., pancreas, colon, blood vessels or bones.
  • Other malignant disease diagnosed or treated up to 2 years prior to inclusion, except non-aggressive cancers such as non-melanoma sin cancer.
  • Altered anatomy of the upper gastrointestinal tract due to previous surgery of the oesophagus, stomach, and duodenum.
  • BMI ≤ 18
  • The patient is unable to understand and/or read the consent form.
  • Other serious illness or acute infections.
  • Pregnant or breastfeeding.

Interventions

PROCEDUREMetastatectomia and standard treatment for resectable disease.

Rather than palliative chemotherapy, the intervention offered to participants is preoperative chemotherapy, resection of primary tumour and metastatectomia of oligometastatic spread to the liver. If fit for post-operative chemotherapy, this is offered as well.


Locations(1)

Aarhus Univercity hospital

Aarhus, Jylland, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06627634


Related Trials